Retreatment of Recurrent Carcinoma of the Head and Neck by Afterloading Interstitial 192IR Implant
- 1 October 1983
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 93 (10) , 1345-1347
- https://doi.org/10.1002/lary.1983.93.10.1345
Abstract
From January 1975 to December 1980, 25 patients with persistent or recurrent carcinomas of the head and neck were retreated for palliation at the Division of Radiation Oncology, Mallinckrodt Institute of Radiology. These patients had all undergone extensive previous treatment by surgery and/or radiation. All were retreated with 192Ir interstitial implant with or without external radiation and/or surgical excision. Of 25 patients, 13 had complete response (CR) and 6 had partial response for a follow‐up period of 1 to 7 years. Of 13 patients with CR, 6 are alive with no evidence of disease (NED) and two died NED. We present detailed results and discuss our new strategy for such patients.Keywords
This publication has 6 references indexed in Scilit:
- Combination chemotherapy with vinblastine, bleomycin, and cis‐diamminedichloroplatinum (ii) in squamous cell carcinoma of the head and neckCancer, 1980
- Combination chemotherapy with cis-diamminedichloroplatinum, oncovin, and bleomycin (COB) in advanced head and neck cancer phase IICancer, 1980
- Chemotherapy prior to local therapy in advanced squamous cell carcinoma of the head and neck. Preliminary assessment of an intensive drug regimenCancer, 1979
- High dose methotrexate with and without BCG therapy in advanced head and neck malignancyCancer, 1979
- Persistent carcinoma of the oropharynx and oral cavity re-treated by after-loading interstitial192Ir implantCancer, 1977
- Regional chemotherapy with combined drugs in cancer of the head and neckCancer, 1976